Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor
Open Access
- 1 August 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (33) , 22498-22504
- https://doi.org/10.1074/jbc.m709080200
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Increased granzyme B production from peripheral blood mononuclear cells in patients with acute coronary syndromeHeart, 2008
- Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicityAtherosclerosis, 2007
- Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritisImmunology Letters, 2007
- The role of Granzyme B in atheromatous diseasesThis paper is one of a selection of papers published in this Special Issue, entitled Young Investigators' Forum.Canadian Journal of Physiology and Pharmacology, 2007
- Extracellular granzymes: current perspectivesBiological Chemistry, 2006
- Extracellular Matrix Remodeling by Human Granzyme B via Cleavage of Vitronectin, Fibronectin, and LamininJournal of Biological Chemistry, 2005
- Cytotoxic activity of the lymphocyte toxin granzyme BMicrobes and Infection, 2004
- The ABCs of granule-mediated cytotoxicity: new weapons in the arsenalNature Reviews Immunology, 2003
- Granzyme B in Atherosclerosis and Transplant Vascular Disease: Association with Cell Death and Atherosclerotic Disease SeverityLaboratory Investigation, 2003
- Lymphocyte-Mediated CytotoxicityAnnual Review of Immunology, 2002